Sign in
Taking people in FranceNo phase

Sinus surgery and sleep in adults with chronic sinus disease and nasal polyps

Looks at sleep problems and how sinus surgery affects sleep in nasal polyps.

Key facts

Who runs it
University Hospital, Lille
Where
Lille, FranceSee the site
Trial code
Registry title
Polysomnographic Findings in Nasal Polyposis
Status
Recruiting
People taking part
30 people, planned
Started
17 Jan 2019
Expected to end
Dec 2026
Type of study
Interventional
Treatments tested
  • Endoscopic sinus surgery
Record updated
6 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with nasal polyps who had endoscopic sinus surgery. It studies how this surgery affects sleep problems.

Age
18 Years and older
Sex
All sexes can join.
Disease stage
Nasal polyps that did not get better with medicine (recalcitrant nasal polyposis).
Earlier treatment
People must have had a 4-month corticosteroid treatment that did not work. People must have had endoscopic sinus surgery for the polyps. People who had nose surgery for polyps before cannot join. People who used CPAP (a breathing machine) for sleep apnea before cannot join.

Main reasons for not taking part

  • Earlier nose surgery for nasal polyps
  • Earlier CPAP breathing machine treatment for obstructive sleep apnea
  • Not covered by the social security system
  • Unable to receive study information or refusing to sign consent
  • Deprived of liberty or under legal protection such as guardianship

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Patients who underwent endoscopic sinus surgery for recalcitrant nasal polyposis (failure of a 4-month corticosteroid medical treatment) Social insured patient
  • Patient willing to comply with all procedures of the study and its duration
  • Patient giving consent

Who cannot take part

  • Patients with previous nasal surgery for nasal polyposis
  • Patients with previous continuous positive airway pressure therapy for obstructive sleep apnea
  • Non-coverage by the social security scheme
  • Patient unable to receive informed information
  • Refusal to sign the consent
  • Person deprived of the liberty
  • Person benefiting from a system of legal protection (guardianship…)

Where in France

  • Hôpital Claude Huriez, CHULille, FranceContact: Geoffrey Mortuaire, MD (principal investigator)Taking people

About the trial

What the trial wants to find out

Nasal polyposis (NP) is a chronic inflammatory disease of the nasal and sinus mucosa leading to protrusion of edematous polyps in the nasal cavity. Prevalence of NP among the chronic rhinosinusitis patients is 25-30 %. NP leads to significant limitations in physical, emotional and social aspects of life of the affected patients. Sleep disorder is frequently reported by those patients with impaired nasal breathing. Till now few studies have objectively assessed the impact of NP on sleep quality. the objectives are to figure out sleep disturbances in NP and to analyze the outcomes of sinus surgery on sleep recovering.

The group in the trial

  • endoscopic sinus surgeryTreatment being tested

    Single group of patients with nasal polyposis eligible for endoscopic sinus surgery

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Effects of Endoscopic Sinus Surgery on Sleep Disorder in Patients With Chronic Rhinosinusitis With Polyps
Plain-language title
Sinus surgery and sleep in adults with chronic sinus disease and nasal polypsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
6 May 2026